Interstitial Cystitis Terminated Phase 3 Trials for Mirabegron (DB08893)

Also known as: Cystitis, Interstitial / Interstitial Cystitides / Cystitis interstitial / Cystitis ulcerative

IndicationStatusPhase
DBCOND0028936 (Interstitial Cystitis)Terminated3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02787083A Pilot Study of the Effects of Mirabegron on Symptoms in Patients With Interstitial CystitisTreatment